Group 1 - The core point of the news is that Innotech's stock price increased by 5.16%, reaching 35.89 CNY per share, with a total market capitalization of 4.916 billion CNY [1] - Innotech specializes in the research, production, and sales of POCT rapid diagnostic products, with a revenue composition of 96.49% from respiratory series, 2.99% from other reagents, and 0.51% from prenatal and postnatal care series [1] Group 2 - Among Innotech's top ten circulating shareholders, a fund under Yongying Fund ranks as a significant holder, while the Medical Device ETF (159883) entered the top ten shareholders in the third quarter, holding 498,000 shares, which is 0.72% of the circulating shares [2] - The Medical Device ETF (159883) was established on April 22, 2021, with a latest scale of 4.73 billion CNY, and has recorded a year-to-date return of 10.13% [2] - The fund manager of the Medical Device ETF is Shu Kefa, who has a total fund asset scale of 6.282 billion CNY, with the best and worst fund returns during his tenure being 103.17% and -30.27%, respectively [2]
英诺特股价涨5.16%,永赢基金旗下1只基金位居十大流通股东,持有49.8万股浮盈赚取87.64万元